Volume 25, Issue 108 (3-2017)                   J Adv Med Biomed Res 2017, 25(108): 68-80 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharifi M, Mousavi S M, Naji T. Effect of Nitrogen-Nano Doped of Titanium Dioxide in Human A-375 Melanoma Cancer Cell Line. J Adv Med Biomed Res 2017; 25 (108) :68-80
URL: http://journal.zums.ac.ir/article-1-3960-en.html
1- Dept. of Cell & Molecular Biology, Islamic Azad University Pharmaceutical Sciences Branch, Tehran, Iran
2- Division of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran
Abstract:   (151657 Views)

Backgrounds and Objective: Titanium dioxide (TiO2) is a potent photosensitizer in photodynamic therapy (PDT) and is activated upon ultraviolet (UV) irradiation.The aim of this study was the assessment of the effect of nitrogen –nano doped of titanium dioxide in human A-375 melanoma cancer cell line.

Materials and Methods: N-TiO2 nanoparticles were prepared by mechanical mixing of urea with TiO2 powder in a 4:1 weight ratio. A-375 cells were treated with different concentrations of N-TiO2 for various time intervals in the presence or absence of visible light. The growth and viability of A-375 cells were determined by means of trypan blue exclusion test and MTT assay, respectively. Acridine orange/Ethidium bromide double staining and DNA gel electrophoresis were applied to determine apoptosis.

Results: The results showed that visible light activated N-TiO2 could induce growth inhibition in a dose (0.01-100 μg/ml ) and time dependent manner. In concentration of 0.5 μg/ml a significant difference was observed between the treated and the control samples.Decrease in viability was observed in 100 μg/ml concentration and the results of fluorescent microscopy showed  DNA fragmentation due to apoptotic cell death[G1]  at this concentration.

Conclusion: Based on the anti-cancer effects of N-TiO2 on A-375 cells, further evaluation of these nanoparticles as a new photosensitizer in photocatalytic therapy of skin cancer can be proposed.


Full-Text [PDF 621 kb]   (157206 Downloads)    
Type of Study: Clinical Trials |
Received: 2016/09/28 | Accepted: 2016/09/28 | Published: 2016/09/28

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb